...a 35 years old man was admitted to our unit with haemorrhagic symptoms….A bone marrow evaluation led to a diagnosis of AML, FAB M2, with normal karyotype, NPM1 exon 11 (W288Cfs*12), FLT3 TKD (D835Y and I836del) and IDH1 (R132H) mutation. An induction chemotherapy with “7+3” associated with midostaurin (days 8-21) was administered and complete remission was obtained.